CorMedix (CRMD) Current Leases (2019 - 2025)
CorMedix (CRMD) posted Current Leases of $596000.0 for Q4 2025, down 29.42% sequentially from $844431.0 in Q3 2025, and up 254.76% YoY from $168000.0 in Q4 2024.
CorMedix (CRMD) Current Leases (2019 - 2025) Analysis & Trends
CorMedix has reported Current Leases for 7 years, with the latest figure at $596000.0 in Q4 2025.
- Quarterly Current Leases rose 254.76% year-over-year to $596000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $596000.0 (up 254.76% YoY) and the FY2025 annual result came in at $596000.0, up 254.76% from the prior year.
- Current Leases fell to $596000.0 in Q4 2025 per CRMD's latest filing, from $844431.0 in the prior quarter.
- Over five years, Current Leases peaked at $844431.0 in Q3 2025 and troughed at $112323.0 in Q1 2021.
- A 5-year average of $199933.6 and a median of $144532.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2025: Current Leases rose 10.22% in 2022, then surged 418.06% in 2025.
- Over 5 years, Current Leases stood at $121368.0 in 2021, then grew by 11.23% to $135000.0 in 2022, then grew by 11.85% to $151000.0 in 2023, then advanced by 11.26% to $168000.0 in 2024, then soared by 254.76% to $596000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $596000.0, $844431.0, and $177000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 596,000.00 |
| Sep 30, 2025 | 844,431.00 |
| Jun 30, 2025 | 177,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 168,000.00 |
| Sep 30, 2024 | 163,000.00 |
| Jun 30, 2024 | 159,000.00 |
| Mar 31, 2024 | 155,000.00 |
| Dec 31, 2023 | 151,000.00 |
| Sep 30, 2023 | 146,531.00 |
| Jun 30, 2023 | 142,533.00 |
| Mar 31, 2023 | 138,623.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | 131,063.00 |
| Jun 30, 2022 | 127,408.00 |
| Mar 31, 2022 | 124,354.00 |
| Dec 31, 2021 | 121,368.00 |
| Sep 30, 2021 | 118,447.00 |
| Jun 30, 2021 | 115,590.00 |
| Mar 31, 2021 | 112,323.00 |